Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Market Cap	4.59B
Revenue (ttm)	906.63M
Net Income (ttm)	192.53M
Shares Out	176.00M
EPS (ttm)	1.17
PE Ratio	22.30
Forward PE	20.95
Dividend	0.30 (1.15%)
Ex-Dividend Date	May 30, 2024

Volume	5,600
Average Volume	37,511
Open	26.30
Previous Close	26.10
Day's Range	26.05 - 26.50
52-Week Range	25.15 - 32.00
Beta	0.24
RSI	46.76
Earnings Date	May 19, 2025

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter use...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 1,735
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1501

Financial Performance

In 2024, HKG:1501's revenue was 851.95 million, an increase of 13.17% compared to the previous year's 752.84 million. Earnings were 180.92 million, an increase of 19.12%.

Financial numbers in CNY